- REPORT SUMMARY
- TABLE OF CONTENTS
-
Nuclear medicine has a huge potential in treating cancer and cardiac diseases. Growth of medical imaging is an opportunity for the growth of the global nuclear medicine radioisotope market, as both markets are correlated. Radiopharmaceuticals are approved by the Food and Drug Administration (FDA) as either drugs or biologics.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Nuclear Medicine Radioisotopes market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Nuclear Medicine Radioisotopes market. Detailed analysis of key players, along with key growth strategies adopted by Nuclear Medicine Radioisotopes industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Curium
Cardiarc
Cardinal Health
Braco
GE Healthcare
Positron
Siemens Healthcare
Nordion (Canada)
NTP Radioisotopes SOC
Segami
Agfa-Gevaert Group
Digirad
By Type:
Thallium-201 (Tl-201)
Iodine (I-123)
Fluorine-18
Rubidium-82 (Rb-82)
Other
By End-User:
Tumor
Heart Disease
Lymphoma
Thyroid Gland
Other
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Nuclear Medicine Radioisotopes Market
-
1.3 Market Segment by Type
-
1.3.1 China Nuclear Medicine Radioisotopes Market Size and Growth Rate of Thallium-201 (Tl-201) from 2016 to 2027
-
1.3.2 China Nuclear Medicine Radioisotopes Market Size and Growth Rate of Iodine (I-123) from 2016 to 2027
-
1.3.3 China Nuclear Medicine Radioisotopes Market Size and Growth Rate of Fluorine-18 from 2016 to 2027
-
1.3.4 China Nuclear Medicine Radioisotopes Market Size and Growth Rate of Rubidium-82 (Rb-82) from 2016 to 2027
-
1.3.5 China Nuclear Medicine Radioisotopes Market Size and Growth Rate of Other from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Nuclear Medicine Radioisotopes Market Size and Growth Rate of Tumor from 2016 to 2027
-
1.4.2 China Nuclear Medicine Radioisotopes Market Size and Growth Rate of Heart Disease from 2016 to 2027
-
1.4.3 China Nuclear Medicine Radioisotopes Market Size and Growth Rate of Lymphoma from 2016 to 2027
-
1.4.4 China Nuclear Medicine Radioisotopes Market Size and Growth Rate of Thyroid Gland from 2016 to 2027
-
1.4.5 China Nuclear Medicine Radioisotopes Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Nuclear Medicine Radioisotopes Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Nuclear Medicine Radioisotopes Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Nuclear Medicine Radioisotopes Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Nuclear Medicine Radioisotopes Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Nuclear Medicine Radioisotopes Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Nuclear Medicine Radioisotopes Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Nuclear Medicine Radioisotopes Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Nuclear Medicine Radioisotopes Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Nuclear Medicine Radioisotopes by Major Types
-
3.4.1 Market Size and Growth Rate of Thallium-201 (Tl-201)
-
3.4.2 Market Size and Growth Rate of Iodine (I-123)
-
3.4.3 Market Size and Growth Rate of Fluorine-18
-
3.4.4 Market Size and Growth Rate of Rubidium-82 (Rb-82)
-
3.4.5 Market Size and Growth Rate of Other
4 Segmentation of Nuclear Medicine Radioisotopes Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Nuclear Medicine Radioisotopes by Major End-Users
-
4.4.1 Market Size and Growth Rate of Nuclear Medicine Radioisotopes in Tumor
-
4.4.2 Market Size and Growth Rate of Nuclear Medicine Radioisotopes in Heart Disease
-
4.4.3 Market Size and Growth Rate of Nuclear Medicine Radioisotopes in Lymphoma
-
4.4.4 Market Size and Growth Rate of Nuclear Medicine Radioisotopes in Thyroid Gland
-
4.4.5 Market Size and Growth Rate of Nuclear Medicine Radioisotopes in Other
5 Market Analysis by Regions
-
5.1 China Nuclear Medicine Radioisotopes Production Analysis by Regions
-
5.2 China Nuclear Medicine Radioisotopes Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Nuclear Medicine Radioisotopes Landscape Analysis
-
6.1 North China Nuclear Medicine Radioisotopes Landscape Analysis by Major Types
-
6.2 North China Nuclear Medicine Radioisotopes Landscape Analysis by Major End-Users
7 Central China Nuclear Medicine Radioisotopes Landscape Analysis
-
7.1 Central China Nuclear Medicine Radioisotopes Landscape Analysis by Major Types
-
7.2 Central China Nuclear Medicine Radioisotopes Landscape Analysis by Major End-Users
8 South China Nuclear Medicine Radioisotopes Landscape Analysis
-
8.1 South China Nuclear Medicine Radioisotopes Landscape Analysis by Major Types
-
8.2 South China Nuclear Medicine Radioisotopes Landscape Analysis by Major End-Users
9 East China Nuclear Medicine Radioisotopes Landscape Analysis
-
9.1 East China Nuclear Medicine Radioisotopes Landscape Analysis by Major Types
-
9.2 East China Nuclear Medicine Radioisotopes Landscape Analysis by Major End-Users
10 Northeast China Nuclear Medicine Radioisotopes Landscape Analysis
-
10.1 Northeast China Nuclear Medicine Radioisotopes Landscape Analysis by Major Types
-
10.2 Northeast China Nuclear Medicine Radioisotopes Landscape Analysis by Major End-Users
11 Southwest China Nuclear Medicine Radioisotopes Landscape Analysis
-
11.1 Southwest China Nuclear Medicine Radioisotopes Landscape Analysis by Major Types
-
11.2 Southwest China Nuclear Medicine Radioisotopes Landscape Analysis by Major End-Users
12 Northwest China Nuclear Medicine Radioisotopes Landscape Analysis
-
12.1 Northwest China Nuclear Medicine Radioisotopes Landscape Analysis by Major Types
-
12.2 Northwest China Nuclear Medicine Radioisotopes Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Curium
-
13.1.1 Curium Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Cardiarc
-
13.2.1 Cardiarc Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Cardinal Health
-
13.3.1 Cardinal Health Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Braco
-
13.4.1 Braco Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 GE Healthcare
-
13.5.1 GE Healthcare Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Positron
-
13.6.1 Positron Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Siemens Healthcare
-
13.7.1 Siemens Healthcare Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Nordion (Canada)
-
13.8.1 Nordion (Canada) Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 NTP Radioisotopes SOC
-
13.9.1 NTP Radioisotopes SOC Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Segami
-
13.10.1 Segami Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 Agfa-Gevaert Group
-
13.11.1 Agfa-Gevaert Group Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
-
13.12 Digirad
-
13.12.1 Digirad Company Profile and Recent Development
-
13.12.2 Market Performance
-
13.12.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Nuclear Medicine Radioisotopes Market Size and Growth Rate of Thallium-201 (Tl-201) from 2016 to 2027
-
Figure China Nuclear Medicine Radioisotopes Market Size and Growth Rate of Iodine (I-123) from 2016 to 2027
-
Figure China Nuclear Medicine Radioisotopes Market Size and Growth Rate of Fluorine-18 from 2016 to 2027
-
Figure China Nuclear Medicine Radioisotopes Market Size and Growth Rate of Rubidium-82 (Rb-82) from 2016 to 2027
-
Figure China Nuclear Medicine Radioisotopes Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Nuclear Medicine Radioisotopes Market Size and Growth Rate of Tumor from 2016 to 2027
-
Figure China Nuclear Medicine Radioisotopes Market Size and Growth Rate of Heart Disease from 2016 to 2027
-
Figure China Nuclear Medicine Radioisotopes Market Size and Growth Rate of Lymphoma from 2016 to 2027
-
Figure China Nuclear Medicine Radioisotopes Market Size and Growth Rate of Thyroid Gland from 2016 to 2027
-
Figure China Nuclear Medicine Radioisotopes Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Nuclear Medicine Radioisotopes Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Nuclear Medicine Radioisotopes Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Nuclear Medicine Radioisotopes Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Nuclear Medicine Radioisotopes Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Nuclear Medicine Radioisotopes Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Nuclear Medicine Radioisotopes Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Nuclear Medicine Radioisotopes Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Nuclear Medicine Radioisotopes Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Nuclear Medicine Radioisotopes
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Nuclear Medicine Radioisotopes by Different Types from 2016 to 2027
-
Table Consumption Share of Nuclear Medicine Radioisotopes by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Thallium-201 (Tl-201)
-
Figure Market Size and Growth Rate of Iodine (I-123)
-
Figure Market Size and Growth Rate of Fluorine-18
-
Figure Market Size and Growth Rate of Rubidium-82 (Rb-82)
-
Figure Market Size and Growth Rate of Other
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Nuclear Medicine Radioisotopes by Different End-Users from 2016 to 2027
-
Table Consumption Share of Nuclear Medicine Radioisotopes by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Tumor
-
Figure Market Size and Growth Rate of Heart Disease
-
Figure Market Size and Growth Rate of Lymphoma
-
Figure Market Size and Growth Rate of Thyroid Gland
-
Figure Market Size and Growth Rate of Other
-
Table China Nuclear Medicine Radioisotopes Production by Regions
-
Table China Nuclear Medicine Radioisotopes Production Share by Regions
-
Figure China Nuclear Medicine Radioisotopes Production Share by Regions in 2016
-
Figure China Nuclear Medicine Radioisotopes Production Share by Regions in 2021
-
Figure China Nuclear Medicine Radioisotopes Production Share by Regions in 2027
-
Table China Nuclear Medicine Radioisotopes Consumption by Regions
-
Table China Nuclear Medicine Radioisotopes Consumption Share by Regions
-
Figure China Nuclear Medicine Radioisotopes Consumption Share by Regions in 2016
-
Figure China Nuclear Medicine Radioisotopes Consumption Share by Regions in 2021
-
Figure China Nuclear Medicine Radioisotopes Consumption Share by Regions in 2027
-
Table North China Nuclear Medicine Radioisotopes Consumption by Types from 2016 to 2027
-
Table North China Nuclear Medicine Radioisotopes Consumption Share by Types from 2016 to 2027
-
Figure North China Nuclear Medicine Radioisotopes Consumption Share by Types in 2016
-
Figure North China Nuclear Medicine Radioisotopes Consumption Share by Types in 2021
-
Figure North China Nuclear Medicine Radioisotopes Consumption Share by Types in 2027
-
Table North China Nuclear Medicine Radioisotopes Consumption by End-Users from 2016 to 2027
-
Table North China Nuclear Medicine Radioisotopes Consumption Share by End-Users from 2016 to 2027
-
Figure North China Nuclear Medicine Radioisotopes Consumption Share by End-Users in 2016
-
Figure North China Nuclear Medicine Radioisotopes Consumption Share by End-Users in 2021
-
Figure North China Nuclear Medicine Radioisotopes Consumption Share by End-Users in 2027
-
Table Central China Nuclear Medicine Radioisotopes Consumption by Types from 2016 to 2027
-
Table Central China Nuclear Medicine Radioisotopes Consumption Share by Types from 2016 to 2027
-
Figure Central China Nuclear Medicine Radioisotopes Consumption Share by Types in 2016
-
Figure Central China Nuclear Medicine Radioisotopes Consumption Share by Types in 2021
-
Figure Central China Nuclear Medicine Radioisotopes Consumption Share by Types in 2027
-
Table Central China Nuclear Medicine Radioisotopes Consumption by End-Users from 2016 to 2027
-
Table Central China Nuclear Medicine Radioisotopes Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Nuclear Medicine Radioisotopes Consumption Share by End-Users in 2016
-
Figure Central China Nuclear Medicine Radioisotopes Consumption Share by End-Users in 2021
-
Figure Central China Nuclear Medicine Radioisotopes Consumption Share by End-Users in 2027
-
Table South China Nuclear Medicine Radioisotopes Consumption by Types from 2016 to 2027
-
Table South China Nuclear Medicine Radioisotopes Consumption Share by Types from 2016 to 2027
-
Figure South China Nuclear Medicine Radioisotopes Consumption Share by Types in 2016
-
Figure South China Nuclear Medicine Radioisotopes Consumption Share by Types in 2021
-
Figure South China Nuclear Medicine Radioisotopes Consumption Share by Types in 2027
-
Table South China Nuclear Medicine Radioisotopes Consumption by End-Users from 2016 to 2027
-
Table South China Nuclear Medicine Radioisotopes Consumption Share by End-Users from 2016 to 2027
-
Figure South China Nuclear Medicine Radioisotopes Consumption Share by End-Users in 2016
-
Figure South China Nuclear Medicine Radioisotopes Consumption Share by End-Users in 2021
-
Figure South China Nuclear Medicine Radioisotopes Consumption Share by End-Users in 2027
-
Table East China Nuclear Medicine Radioisotopes Consumption by Types from 2016 to 2027
-
Table East China Nuclear Medicine Radioisotopes Consumption Share by Types from 2016 to 2027
-
Figure East China Nuclear Medicine Radioisotopes Consumption Share by Types in 2016
-
Figure East China Nuclear Medicine Radioisotopes Consumption Share by Types in 2021
-
Figure East China Nuclear Medicine Radioisotopes Consumption Share by Types in 2027
-
Table East China Nuclear Medicine Radioisotopes Consumption by End-Users from 2016 to 2027
-
Table East China Nuclear Medicine Radioisotopes Consumption Share by End-Users from 2016 to 2027
-
Figure East China Nuclear Medicine Radioisotopes Consumption Share by End-Users in 2016
-
Figure East China Nuclear Medicine Radioisotopes Consumption Share by End-Users in 2021
-
Figure East China Nuclear Medicine Radioisotopes Consumption Share by End-Users in 2027
-
Table Northeast China Nuclear Medicine Radioisotopes Consumption by Types from 2016 to 2027
-
Table Northeast China Nuclear Medicine Radioisotopes Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Nuclear Medicine Radioisotopes Consumption Share by Types in 2016
-
Figure Northeast China Nuclear Medicine Radioisotopes Consumption Share by Types in 2021
-
Figure Northeast China Nuclear Medicine Radioisotopes Consumption Share by Types in 2027
-
Table Northeast China Nuclear Medicine Radioisotopes Consumption by End-Users from 2016 to 2027
-
Table Northeast China Nuclear Medicine Radioisotopes Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Nuclear Medicine Radioisotopes Consumption Share by End-Users in 2016
-
Figure Northeast China Nuclear Medicine Radioisotopes Consumption Share by End-Users in 2021
-
Figure Northeast China Nuclear Medicine Radioisotopes Consumption Share by End-Users in 2027
-
Table Southwest China Nuclear Medicine Radioisotopes Consumption by Types from 2016 to 2027
-
Table Southwest China Nuclear Medicine Radioisotopes Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Nuclear Medicine Radioisotopes Consumption Share by Types in 2016
-
Figure Southwest China Nuclear Medicine Radioisotopes Consumption Share by Types in 2021
-
Figure Southwest China Nuclear Medicine Radioisotopes Consumption Share by Types in 2027
-
Table Southwest China Nuclear Medicine Radioisotopes Consumption by End-Users from 2016 to 2027
-
Table Southwest China Nuclear Medicine Radioisotopes Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Nuclear Medicine Radioisotopes Consumption Share by End-Users in 2016
-
Figure Southwest China Nuclear Medicine Radioisotopes Consumption Share by End-Users in 2021
-
Figure Southwest China Nuclear Medicine Radioisotopes Consumption Share by End-Users in 2027
-
Table Northwest China Nuclear Medicine Radioisotopes Consumption by Types from 2016 to 2027
-
Table Northwest China Nuclear Medicine Radioisotopes Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Nuclear Medicine Radioisotopes Consumption Share by Types in 2016
-
Figure Northwest China Nuclear Medicine Radioisotopes Consumption Share by Types in 2021
-
Figure Northwest China Nuclear Medicine Radioisotopes Consumption Share by Types in 2027
-
Table Northwest China Nuclear Medicine Radioisotopes Consumption by End-Users from 2016 to 2027
-
Table Northwest China Nuclear Medicine Radioisotopes Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Nuclear Medicine Radioisotopes Consumption Share by End-Users in 2016
-
Figure Northwest China Nuclear Medicine Radioisotopes Consumption Share by End-Users in 2021
-
Figure Northwest China Nuclear Medicine Radioisotopes Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Curium
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Curium
-
Figure Sales and Growth Rate Analysis of Curium
-
Figure Revenue and Market Share Analysis of Curium
-
Table Product and Service Introduction of Curium
-
Table Company Profile and Development Status of Cardiarc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cardiarc
-
Figure Sales and Growth Rate Analysis of Cardiarc
-
Figure Revenue and Market Share Analysis of Cardiarc
-
Table Product and Service Introduction of Cardiarc
-
Table Company Profile and Development Status of Cardinal Health
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cardinal Health
-
Figure Sales and Growth Rate Analysis of Cardinal Health
-
Figure Revenue and Market Share Analysis of Cardinal Health
-
Table Product and Service Introduction of Cardinal Health
-
Table Company Profile and Development Status of Braco
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Braco
-
Figure Sales and Growth Rate Analysis of Braco
-
Figure Revenue and Market Share Analysis of Braco
-
Table Product and Service Introduction of Braco
-
Table Company Profile and Development Status of GE Healthcare
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GE Healthcare
-
Figure Sales and Growth Rate Analysis of GE Healthcare
-
Figure Revenue and Market Share Analysis of GE Healthcare
-
Table Product and Service Introduction of GE Healthcare
-
Table Company Profile and Development Status of Positron
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Positron
-
Figure Sales and Growth Rate Analysis of Positron
-
Figure Revenue and Market Share Analysis of Positron
-
Table Product and Service Introduction of Positron
-
Table Company Profile and Development Status of Siemens Healthcare
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Siemens Healthcare
-
Figure Sales and Growth Rate Analysis of Siemens Healthcare
-
Figure Revenue and Market Share Analysis of Siemens Healthcare
-
Table Product and Service Introduction of Siemens Healthcare
-
Table Company Profile and Development Status of Nordion (Canada)
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nordion (Canada)
-
Figure Sales and Growth Rate Analysis of Nordion (Canada)
-
Figure Revenue and Market Share Analysis of Nordion (Canada)
-
Table Product and Service Introduction of Nordion (Canada)
-
Table Company Profile and Development Status of NTP Radioisotopes SOC
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of NTP Radioisotopes SOC
-
Figure Sales and Growth Rate Analysis of NTP Radioisotopes SOC
-
Figure Revenue and Market Share Analysis of NTP Radioisotopes SOC
-
Table Product and Service Introduction of NTP Radioisotopes SOC
-
Table Company Profile and Development Status of Segami
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Segami
-
Figure Sales and Growth Rate Analysis of Segami
-
Figure Revenue and Market Share Analysis of Segami
-
Table Product and Service Introduction of Segami
-
Table Company Profile and Development Status of Agfa-Gevaert Group
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Agfa-Gevaert Group
-
Figure Sales and Growth Rate Analysis of Agfa-Gevaert Group
-
Figure Revenue and Market Share Analysis of Agfa-Gevaert Group
-
Table Product and Service Introduction of Agfa-Gevaert Group
-
Table Company Profile and Development Status of Digirad
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Digirad
-
Figure Sales and Growth Rate Analysis of Digirad
-
Figure Revenue and Market Share Analysis of Digirad
-
Table Product and Service Introduction of Digirad
-

Chinese